Dissecting Immunotherapy Strategies for Small Cell Lung Cancer: Antibodies, Ionizing Radiation and CAR-T

Small cell lung cancer (SCLC) is a highly aggressive malignancy that accounts for about 14% of all lung cancers. Platinum-based chemotherapy has been the only available treatment for a long time, until the introduction of immune checkpoint inhibitors (ICIs) recently changed first-line standard of ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Guaitoli, Giorgia, Neri, Giovanni, Cabitza, Eleonora, Natalizio, Salvatore, Mastrodomenico, Luciana, Talerico, Sabrina, Trudu, Lucia, Lauro, Chiara, Chiavelli, Chiara, Baschieri, Maria Cristina, Bruni, Alessio, Dominici, Massimo, Bertolini, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656696/
https://www.ncbi.nlm.nih.gov/pubmed/36361523
http://dx.doi.org/10.3390/ijms232112728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656696/
https://www.ncbi.nlm.nih.gov/pubmed/36361523
http://dx.doi.org/10.3390/ijms232112728

Ejemplares similares